Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

R Gunkel, D A Newsome, D S Finbloom, K Silver, Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. The Journal of Rheumatology. ,vol. 12, pp. 692- 694 ,(1985)

Johansen Pb, Gran Jt, Ototoxicity due to hydroxychloroquine : Report of two cases Clinical and Experimental Rheumatology. ,vol. 16, pp. 472- 474 ,(1998)

K C Kalunian, G S Alarcón, M J Egger, R F Willkens, D O Clegg, J Z Singer, H J Williams, J L Skosey, R H Brooks, V D Steen, Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus. The Journal of Rheumatology. ,vol. 21, pp. 1457- 1462 ,(1994)

Michael F Marmor, Ronald E Carr, Michael Easterbrook, Ayad A Farjo, William F Mieler, Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: A report by the American Academy of Ophthalmology Ophthalmology. ,vol. 109, pp. 1377- 1382 ,(2002) , 10.1016/S0161-6420(02)01168-5

B Hernández-Cruz, N Tapia, AR Villa-Romero, E Reyes, MH Cardiel, None, Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clinical and Experimental Rheumatology. ,vol. 19, pp. 395- 401 ,(2001)

David Atkins, Dana Best, Peter Briss, Martin Eccles, Yngve Falck-Ytter, Signe Flottorp, Gordon Guyatt, Robin Harbour, Margaret Haugh, David Henry, Suzanne Hill, Roman Jaeschke, Gillian Leng, Alessandro Liberati, Jacek Mrukowicz Nicola Magrini, James Mason, Philippa Middleton, Dianne O'Connell, Andrew D Oxman, Bob Phillips, Holger J Schünemann, Tessa Tan-Torres Edejer, Helena Varonen, Gunn Vist, John Williams Jr, Stephanie Zaza, Grading quality of evidence and strength of recommendations. BMJ. ,vol. 328, pp. 1490- 1490 ,(2004) , 10.1136/BMJ.328.7454.1490

Graciela S. Alarcón, How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy? Arthritis & Rheumatism. ,vol. 46, pp. 561- 561 ,(2002) , 10.1002/ART.10054

M. Schneider, EULAR-Empfehlungen zur Behandlung des systemischen Lupus erythematodes Zeitschrift Fur Rheumatologie. ,vol. 68, pp. 578- 583 ,(2009) , 10.1007/S00393-009-0463-1

J.F. Muñoz-Valle, M. Vázquez-Del Mercado, S. Ruiz-Quezada, E. Oregón-Romero, R.E. Navarro-Hernández, J. Ramírez-Barragán, G. Martínez-Bonilla, G. Bernard-Medina, B.E. Bastidas-Ramírez, B. Ruiz-Madrigal, A. Panduro, Polymorphism of the β3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine Rheumatology International. ,vol. 23, pp. 99- 103 ,(2003) , 10.1007/S00296-002-0266-Z

Ola Nived, Ellen Ginzler, Murray B. Urowitz, Paul Bacon, John G. Hanly, Gunnar Sturfelt, David A. Isenberg, Charles H. Goldsmith, Caroline Gordon, Dafna D. Gladman, Michael Snaith, Paul Fortin, Michelle Petri, The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. The Journal of Rheumatology. ,vol. 27, pp. 373- 376 ,(2000)